By proceeding, you agree to our Terms of Use and Privacy Policy.
Radha Krishnan Distinguished Scientist at Merck
Talks About #scientist
Preferred Locations #Europe
NASH continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing our understanding of the disease’s mechanisms.